GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.70 $7.70 Friday, 19th Apr 2024 FATE stock ended at $4.79. This is 4.96% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 8.84% from a day low at $4.70 to a day high of $5.11.
90 days $4.40 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2023-10-19 $2.00 $2.09 $1.95 $2.05 2 281 252
2023-10-18 $1.97 $2.19 $1.90 $2.01 3 333 681
2023-10-17 $1.75 $2.05 $1.73 $2.02 1 668 398
2023-10-16 $1.71 $1.79 $1.67 $1.77 1 939 361
2023-10-13 $1.73 $1.77 $1.68 $1.70 673 485
2023-10-12 $1.85 $1.86 $1.74 $1.75 1 496 242
2023-10-11 $1.87 $1.91 $1.79 $1.82 619 395
2023-10-10 $1.76 $1.90 $1.74 $1.87 914 997
2023-10-09 $1.77 $1.78 $1.70 $1.76 859 311
2023-10-06 $1.74 $1.79 $1.66 $1.78 1 088 664
2023-10-05 $1.72 $1.81 $1.68 $1.76 1 920 163
2023-10-04 $1.84 $1.86 $1.72 $1.76 1 385 435
2023-10-03 $1.90 $1.90 $1.76 $1.84 1 812 731
2023-10-02 $2.12 $2.12 $1.89 $1.92 1 542 400
2023-09-29 $2.18 $2.24 $2.11 $2.12 1 321 830
2023-09-28 $2.08 $2.19 $2.03 $2.18 1 540 351
2023-09-27 $2.03 $2.13 $2.00 $2.10 1 451 324
2023-09-26 $2.06 $2.22 $1.99 $2.02 1 302 437
2023-09-25 $2.09 $2.15 $2.01 $2.08 1 746 556
2023-09-22 $2.22 $2.23 $2.10 $2.11 1 643 189
2023-09-21 $2.21 $2.22 $2.11 $2.19 2 462 883
2023-09-20 $2.34 $2.38 $2.25 $2.25 1 394 117
2023-09-19 $2.48 $2.54 $2.29 $2.35 4 210 422
2023-09-18 $2.25 $2.63 $2.23 $2.55 7 435 955
2023-09-15 $2.36 $2.39 $2.14 $2.20 17 604 009
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT